← Leaderboards
Nicholas A Butowski
University Of California, San Francisco
$1,763,446
Attributed
$1,763,446
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.1M · FY2014–25$2M$1.5M$1M$500K$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,928,303 · 4
By mechanism
U19$5,277,162 · 3
R21$651,141 · 1
Top collaborators
- Roger Stupp5 shared
Most similar at University Of California, San Francisco
Same institution · by research overlap
- Hideho Okada$20,052,698
- Edward Chang$31,820,733
- William A Weiss$31,543,847
- Ralph S Marcucio$11,671,496
- Michael D. Taylor$7,522,868
Others in their field
Top investigators on “Brain Neoplasms”
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,967,203
- David Heimbrook · Leidos Biomedical Research, Inc.$145,442,397
- Walter John Curran · Thomas Jefferson University$98,312,615
- Gregory H Reaman · National Childhood Cancer Foundation$78,833,655
- Todd A Alonzo · University Of Colorado Denver/Hsc Denver$72,436,447
- Robert H Vonderheide · University Of Pennsylvania$60,987,353
Research focus
Brain NeoplasmsClinical TrialsGrantDesignImmunotherapyPilot ProjectsCollaborationsGlioblastomaUniversitiesInstitutionResourcesResearch Project GrantsUnited States National Institutes Of HealthFundingNeuro-OncologyResearch PersonnelBasePre-ClinicalPre-Clinical ModelMonitorPharmaceutical PreparationsRecurrenceIndustry PartnerBrain
Grant awards (12)
Advancing treatment and understanding of immunotherapy in glioblastoma$838,812
U19 · FY2025 · CA · contact PI
Administrative and Clinical Services Core$223,408
U19 · FY2025 · CA · contact PI
Advancing treatment and understanding of immunotherapy in glioblastoma$796,871
U19 · FY2024 · CA · contact PI
Administrative and Clinical Services Core$212,238
U19 · FY2024 · CA · contact PI
Advancing treatment and understanding of immunotherapy in glioblastoma$821,970
U19 · FY2023 · CA · contact PI
Administrative and Clinical Services Core$218,939
U19 · FY2023 · CA · contact PI
Advancing treatment and understanding of immunotherapy in glioblastoma$821,968
U19 · FY2022 · CA · contact PI
Administrative and Clinical Services Core$218,939
U19 · FY2022 · CA · contact PI
Advancing treatment and understanding of immunotherapy in glioblastoma$885,236
U19 · FY2021 · CA · contact PI
Administrative and Clinical Services Core$238,781
U19 · FY2021 · CA · contact PI
A Phase I Study of CED of Liposomal-Irinotecan using imaging in High Grade Glioma$326,206
R21 · FY2015 · CA · contact PI
A Phase I Study of CED of Liposomal-Irinotecan using imaging in High Grade Glioma$324,935
R21 · FY2014 · CA · contact PI